| ￥3000 | |
| Z06085-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | E.coli | ||||
| Theoretical Molecular Weight | 14.31 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 14.31 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22μm filtered solution in 50mM Tris, 200mM NaCl, 10% Glycerol (pH 8.0). | ||||
| Concentration | Verified by one or more methods from 0.64mg/ml A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | D-dopachrome tautomerase (D-DT) is a newly described cytokine and a member of the macrophage migration inhibitory factor (MIF) protein superfamily.The D-DT protein also is present in most tissues and circulates in serum at similar concentrations as MIF. D-DT binds the MIF cell surface receptor complex, CD74/CD44, with high affinity and induces similar cell signaling and effector functions. |
| Synonyms | D-DT; D-dopachrome decarboxylase; D-dopachrome tautomerase; Phenylpyruvate tautomerase II; EC 4.1.1.84; MIF2; DDCT |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
